As part of the IT Bridge project, our CEO Kateryna Solovei, together with colleagues from Kharkiv IT Cluster and IT Dnipro Community, visited the Oracle Barcelona office — a company that sets the pace in the world of cloud technologies.

Their office is located in the legendary Torre Agbar and occupies four floors of this 34-story building — one of the symbols of Barcelona’s tech district. It is home to the European Oracle Health Support Center, where specialists work on AI-driven solutions to modernize healthcare systems.

The space combines innovative design with areas for collaboration and focus — a true hub of future technologies.

💡 Oracle is among the global market leaders, and its clients include even major competitors like X, Amazon, Meta, and others.

During a meeting with Joan Planella, Director of the Barcelona office, and his team, we witnessed what the new era of healthcare looks like:

the doctor communicates with the patient, prescribes treatment, and everything is automatically recorded in the system.

🧠 AI agents generate diagnoses, prescriptions, referrals, and reminders for patients — and if the doctor makes an error, the system analyzes and corrects it.

This is not the future — this is reality that’s already changing lives.

And that’s why it’s crucial for the Ukrainian IT ecosystem to be alongside global players.

Despite the war, Oracle remains in Ukraine — including in Odesa, where the company has an office.

It’s worth noting that one of its representatives, Ihor Bushniak, was among the participants of the very first meeting that initiated the creation of Odesa IT Family.

The Barcelona office, by the way, is a member of the Catalonia Technology Cluster, and its director serves as Vice President of the cluster.

🤝 We invite the Ukrainian Oracle office to join our community so that the support of the region and the country becomes even more tangible — and so that the company’s innovative products become available to Ukrainian hospitals and patients.

The ITBridge project is funded by the European Union through the Single Market Programme under the grant agreement №101196018. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.